Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Mustela nivalis genome sequencing

PROVIDER: PRJNA704937 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR13788917_1.fastq.gz	Fastqsanger.gz
	SRR13788917_2.fastq.gz	Fastqsanger.gz
	SRR13788918_1.fastq.gz	Fastqsanger.gz
	SRR13788918_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

Mustela nivalis

Project description:Mustela nivalis overview

| PRJNA194197 | ENA

mMusNiv

Project description:Mustela nivalis (least weasel)

| PRJEB80975 | ENA

Mustela nivalis

Project description:Mustela nivalis (least weasel) draft genome, alternative pseudohaplotype

| PRJNA704796 | ENA

Mustela nivalis

Project description:Mustela nivalis (least weasel) draft genome, primary pseudohaplotype

| PRJNA704797 | ENA

mMusNiv

Project description:Mustela nivalis (least weasel), genomic and transcriptomic data

| PRJEB80974 | ENA

Mustela nivalis

Project description:Linked-read WGS for Mustela nivalis (least weasel) draft genome assembly

| PRJNA704526 | ENA

Project description:Low-coverage WGS of Mustela nivalis (least weasel) populations in Sweden and Poland

| PRJNA704911 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Mustela sibirica

Project description:Mustela sibirica Genome sequencing

| PRJNA730361 | ENA

Conyzicola nivalis strain:2857 | isolate:DPS 2857

Project description:Conyzicola nivalis 2857 genome sequencing

| PRJNA1115652 | ENA